The Expression of Vascular Endothelial Growth Factor and Its Receptors in Congenital Bronchopulmonary Cystic Malformations
European Journal of Pediatric Surgery, 04/26/2012Weber SC et al.
The data suggest a possible role of VEGF–VEGFR2 interaction in the pathogenesis of congenital bronchopulmonary cystic malformations. However, VEGFR2 does not represent a suitable histochemical marker to distinguish between Bronchopulmonary sequestration (BPS) and congenital cystic adenomatoid malformation (CCAM).
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.